Fluicell

Nexocyte

Platform

Biopixlar Single-cell tools Publications Intellectual property

Pipeline

Diabetes Heart disease

Partnerships

About

News & Events Leadership & Advisors Contact

Investors

Press releases Reports Financial calendar Financial documents Management and board The share Annual General Meeting

Contact

EN

EN

SV

EN

SV

/

/

/

Closing the loop on type 1 diabetes

Closing the loop on type 1 diabetes

2023

-

Fluicell

View publication

Share this publication:

Expertise

We are pioneers in high precision tissue engineering and open volume microfluidics, developing the next generation of products for regenerative medicine and drug screening.

Contact

Flöjelbergsgatan 8C 

SE – 431 37 Mölndal 

Sweden

+46 76 208 33 54

info@fluicell.com

More about fluicell

Intellectual property Legal and sales GDPR policy Cookie policy

Follow us

Corporate ID: 556889-3282

VAT: SE556889328201

Fluicell®, Biopen®, Biozone 6®, Biopixlar®, Lab-on-a-tip® and Nexocyte™ are registered trademarks of Fluicell AB, Sweden.